ATE78407T1 - Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten. - Google Patents
Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.Info
- Publication number
- ATE78407T1 ATE78407T1 AT89202588T AT89202588T ATE78407T1 AT E78407 T1 ATE78407 T1 AT E78407T1 AT 89202588 T AT89202588 T AT 89202588T AT 89202588 T AT89202588 T AT 89202588T AT E78407 T1 ATE78407 T1 AT E78407T1
- Authority
- AT
- Austria
- Prior art keywords
- prophylaxis
- autoimmune diseases
- immunotoxins
- treatment respectively
- auto
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88202349 | 1988-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE78407T1 true ATE78407T1 (de) | 1992-08-15 |
Family
ID=8199870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89202588T ATE78407T1 (de) | 1988-10-21 | 1989-10-13 | Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0365087B1 (de) |
| JP (1) | JP2807506B2 (de) |
| KR (1) | KR0151851B1 (de) |
| AT (1) | ATE78407T1 (de) |
| AU (1) | AU625802B2 (de) |
| CA (1) | CA2000999A1 (de) |
| DE (1) | DE68902212T2 (de) |
| DK (1) | DK523589A (de) |
| ES (1) | ES2051989T3 (de) |
| FI (1) | FI100305B (de) |
| GR (1) | GR3006048T3 (de) |
| IE (1) | IE61831B1 (de) |
| NZ (1) | NZ231095A (de) |
| PT (1) | PT92071B (de) |
| ZA (1) | ZA897895B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3423293A (en) * | 1991-12-19 | 1993-07-19 | Baylor College Of Medicine | Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| WO2000009155A1 (en) | 1998-08-11 | 2000-02-24 | Rush-Presbyterian-St.Luke's Medical Center | Methods and compositions for preventing anti-gal production in xenograft recipients |
| KR100346059B1 (ko) * | 1999-12-30 | 2002-07-24 | 주식회사 효성 | 폴리에스테르 섬유의 제조방법 |
| WO2008062288A2 (en) * | 2006-11-23 | 2008-05-29 | Cadila Pharmaceuticals Limited | Poly-tlr antagonist |
| JP7303107B2 (ja) * | 2016-08-12 | 2023-07-04 | イムノワーク，リミテッド ライアビリティ カンパニー | 自己免疫疾患の診断、予防、および／または治療 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69686A (en) * | 1983-09-11 | 1988-03-31 | Yeda Res & Dev | Compositions containing cell membrane proteins and process for their preparation |
| DE3513572A1 (de) * | 1985-04-16 | 1986-10-16 | Karl Prof. Dr.med. 7302 Ostfildern Theurer | Herstellung von praeparaten zur spezifischen beeinflussung der humoralen und zellulaeren immunreaktion |
| NL8701163A (nl) * | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
-
1989
- 1989-10-13 DE DE8989202588T patent/DE68902212T2/de not_active Expired - Fee Related
- 1989-10-13 EP EP89202588A patent/EP0365087B1/de not_active Expired - Lifetime
- 1989-10-13 ES ES89202588T patent/ES2051989T3/es not_active Expired - Lifetime
- 1989-10-13 AT AT89202588T patent/ATE78407T1/de not_active IP Right Cessation
- 1989-10-16 IE IE332489A patent/IE61831B1/en not_active IP Right Cessation
- 1989-10-18 ZA ZA897895A patent/ZA897895B/xx unknown
- 1989-10-19 CA CA002000999A patent/CA2000999A1/en not_active Abandoned
- 1989-10-20 NZ NZ231095A patent/NZ231095A/en unknown
- 1989-10-20 PT PT92071A patent/PT92071B/pt not_active IP Right Cessation
- 1989-10-20 DK DK523589A patent/DK523589A/da not_active Application Discontinuation
- 1989-10-20 AU AU43595/89A patent/AU625802B2/en not_active Ceased
- 1989-10-20 JP JP1274783A patent/JP2807506B2/ja not_active Expired - Lifetime
- 1989-10-20 FI FI895005A patent/FI100305B/fi not_active IP Right Cessation
- 1989-10-21 KR KR1019890015214A patent/KR0151851B1/ko not_active IP Right Cessation
-
1992
- 1992-10-22 GR GR920402373T patent/GR3006048T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT92071A (pt) | 1990-04-30 |
| GR3006048T3 (de) | 1993-06-21 |
| DK523589D0 (da) | 1989-10-20 |
| CA2000999A1 (en) | 1990-04-21 |
| KR0151851B1 (ko) | 1998-10-15 |
| AU4359589A (en) | 1990-04-26 |
| KR900005996A (ko) | 1990-05-07 |
| JP2807506B2 (ja) | 1998-10-08 |
| ZA897895B (en) | 1990-07-25 |
| EP0365087B1 (de) | 1992-07-22 |
| JPH02169523A (ja) | 1990-06-29 |
| IE893324L (en) | 1990-04-21 |
| FI895005A0 (fi) | 1989-10-20 |
| DE68902212D1 (de) | 1992-08-27 |
| IE61831B1 (en) | 1994-11-30 |
| AU625802B2 (en) | 1992-07-16 |
| DK523589A (da) | 1990-04-22 |
| ES2051989T3 (es) | 1994-07-01 |
| PT92071B (pt) | 1995-06-30 |
| NZ231095A (en) | 1992-03-26 |
| FI100305B (fi) | 1997-11-14 |
| EP0365087A1 (de) | 1990-04-25 |
| DE68902212T2 (de) | 1993-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX172600B (es) | , "procedimiento para la produccion de una proteina biologicamente activa | |
| TNSN91029A1 (fr) | Les analogues du nucleoside de 1,3-oxathiolane | |
| NL970039I2 (nl) | Prostaglandinederivaten voor de behandeling van glaucoma of oculaire hypertensie. | |
| FR10C0016I2 (fr) | Procedes et compositions s'appliquant au traitement de la glomerulonephrite | |
| KR890701107A (ko) | 알쯔하이머 병 치료용 화합물들 | |
| FI941245A (fi) | Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi | |
| DE68929388D1 (de) | Aus Harn isolierte antikoagulierende Verbindung | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| ES2043609T3 (es) | Composiciones de interleucina-2. | |
| FI913818A0 (fi) | Nytt trombolytiskt aemne. | |
| ES2064613T3 (es) | Produccion de agentes citotoxicos. | |
| ATE78407T1 (de) | Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten. | |
| FR2687681B1 (fr) | Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses. | |
| FR2651435B1 (de) | ||
| WO1997025071A3 (en) | Immunoconjugate for the treatment of aids | |
| NO891894D0 (no) | Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer. | |
| DE69122960D1 (de) | Verfahren und zubereitungen für die behandlung von verletzungen | |
| BR9506838A (pt) | Derivados de ácido micofenólico substituídos na posição 5 | |
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| FR2646607B1 (fr) | Anticorps monoclonaux anti-b2 microglobuline | |
| NO903408L (no) | Terapeutisk anvendelse av anti-t-celle-immunotoksin for autoimmunsykdommer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |